🔎 Trials Near Me

Domov › Nemalicelični pljučni rak › Tennessee › Memphis

Klinične študije za Nemalicelični pljučni rak v Memphis, TN

23 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Memphis in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Vključevanje udeležencevFaza 3
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi stran
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT04267848

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Vključevanje udeležencevFaza 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi stran
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07293247

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Vključevanje udeležencevFaza 3
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi stran
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06498635

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 3
  • Baptist Cancer Center, Memphis
  • Baptist Clinical Research Institute, Memphis
  • Baptist Cancer Center, Bartlett · 11 mi stran
  • in še 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07144280

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 2
  • Research Site, Memphis
Starost 18–95 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05061550

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

Vključevanje udeležencevFaza 2
  • Baptist Clinical Research Institute, Memphis
Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT06745882

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Vključevanje udeležencevFaza 2/3
  • West Cancer Center & Research Institute - East Campus, Germantown · 14 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT04613596

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 2
  • Baptist Clinical Research Institute, Memphis
Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT04302025

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • Baptist Memorial Hospital-Memphis, Memphis
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Vključevanje udeležencevFaza 3
  • Research Site, Memphis
Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07291037

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Vključevanje udeležencevFaza 1
  • The West Clinic, PLLC dba West Cancer Center, Germantown · 14 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT06764771

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Vključevanje udeležencevFaza 1/2
  • Baptist Medical Center, Memphis
Starost 18 in več · Vsi spoli · Posodobljeno 30. jun. 2026 · NCT06162221

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Vključevanje udeležencevFaza 2
  • Baptist Cancer Center, Memphis
Starost 18–70 · Vsi spoli · Posodobljeno 26. jun. 2026 · NCT04614103

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi stran
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05642572

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Vključevanje udeležencevFaza 1/2
  • Baptist Memorial Hospital Baptist Cancer Center, Memphis
Starost 12 in več · Vsi spoli · Posodobljeno 27. maj 2026 · NCT03093116

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi stran
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 6. maj 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2/3
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi stran
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi stran
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi stran
18 Minutes · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Vključevanje udeležencevOpazovalna študija
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital for Women, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southaven · 11 mi stran
  • in še 1
Starost 18 in več · Vsi spoli · Posodobljeno 17. mar. 2026 · NCT06418204

GEMINI-NSCLC: NSCLC Biomarker Study

Vključevanje udeležencevOpazovalna študija
  • Baptist Cancer Center, Memphis
Starost 18 in več · Vsi spoli · Posodobljeno 5. feb. 2026 · NCT05236114

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Vključevanje udeležencevOpazovalna študija
  • Massive Bio SYNERGY-AI site, Memphis
Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

Študije za Nemalicelični pljučni rak v drugih mestih

Druge študije v Memphis

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.